May. 27 at 5:18 PM
$CUE | SMALL-CAP BIOTECH SETUP WITH BIG RE-RATE ENERGY
NASDAQ-listed, fresh
$30M private placement, Phase 2 exposure with CUE-221, and Big Pharma validation through Boehringer Ingelheim.
Key Levels:
✅ Reaccumulation:
$18.29–
$22.30
✅ Breakout:
$25.56
✅ Major resistance:
$30.74–
$33.08
✅ Target:
$41.35+
As long as CUE holds this reaccumulation zone, the structure stays constructive.
A move over
$25.56 could bring momentum back fast and clearing
$33.08 puts
$41.35+ in play.
Small-cap biotech can move quick when capital, catalysts, and technicals line up. 🔥
Communicated - Disclaimer:
https://stockresearchtoday.com/cue/
Sector Peers:
$LLY $JNJ $MRK $ABBV
